Free Trial

XY Planning Network Inc. Acquires Shares of 7,475 CME Group Inc. $CME

CME Group logo with Finance background

Key Points

  • XY Planning Network Inc. has acquired 7,475 shares of CME Group Inc. valued at approximately $2,060,000 during the 2nd quarter.
  • Institutional investors hold about 87.75% of CME Group's stock, with notable increases in share ownership from several large investors recently.
  • CME Group reported a 10.4% increase in revenue year-over-year and exceeded earnings estimates with an EPS of $2.96 for the last quarter.
  • Interested in CME Group? Here are five stocks we like better.

XY Planning Network Inc. acquired a new stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 7,475 shares of the financial services provider's stock, valued at approximately $2,060,000.

Several other large investors have also bought and sold shares of CME. Wealth Enhancement Advisory Services LLC boosted its position in CME Group by 4.3% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 64,452 shares of the financial services provider's stock valued at $14,968,000 after acquiring an additional 2,686 shares in the last quarter. GAMMA Investing LLC boosted its position in shares of CME Group by 32,941.0% in the 1st quarter. GAMMA Investing LLC now owns 1,858,887 shares of the financial services provider's stock worth $493,144,000 after purchasing an additional 1,853,261 shares in the last quarter. Rothschild Investment LLC boosted its position in shares of CME Group by 2.6% in the 1st quarter. Rothschild Investment LLC now owns 2,181 shares of the financial services provider's stock worth $579,000 after purchasing an additional 55 shares in the last quarter. Meyer Handelman Co. boosted its position in shares of CME Group by 84.4% in the 1st quarter. Meyer Handelman Co. now owns 48,793 shares of the financial services provider's stock worth $12,944,000 after purchasing an additional 22,336 shares in the last quarter. Finally, Bowman & Co S.C. boosted its position in shares of CME Group by 7.1% in the 1st quarter. Bowman & Co S.C. now owns 9,226 shares of the financial services provider's stock worth $2,447,000 after purchasing an additional 614 shares in the last quarter. 87.75% of the stock is owned by institutional investors.

Insider Buying and Selling

In other CME Group news, Director William R. Shepard purchased 262 shares of the business's stock in a transaction on Thursday, September 25th. The stock was acquired at an average price of $265.19 per share, for a total transaction of $69,479.78. Following the purchase, the director owned 258,459 shares of the company's stock, valued at approximately $68,540,742.21. This represents a 0.10% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, General Counsel Jonathan L. Marcus sold 392 shares of the stock in a transaction on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total value of $102,704.00. Following the completion of the sale, the general counsel owned 7,851 shares of the company's stock, valued at $2,056,962. The trade was a 4.76% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 13,043 shares of company stock valued at $3,527,956. Company insiders own 0.30% of the company's stock.

CME Group Trading Up 0.6%

NASDAQ:CME opened at $270.28 on Friday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a market capitalization of $97.40 billion, a price-to-earnings ratio of 26.16, a price-to-earnings-growth ratio of 4.89 and a beta of 0.43. CME Group Inc. has a one year low of $213.94 and a one year high of $290.79. The business has a fifty day moving average price of $270.87 and a 200-day moving average price of $270.96.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping the consensus estimate of $2.91 by $0.05. The firm had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.CME Group's revenue was up 10.4% on a year-over-year basis. During the same period in the prior year, the business posted $2.56 EPS. Sell-side analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were paid a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.8%. The ex-dividend date was Tuesday, September 9th. CME Group's dividend payout ratio is 48.40%.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. Barclays set a $298.00 price target on CME Group and gave the stock an "equal weight" rating in a research report on Thursday, July 24th. JPMorgan Chase & Co. boosted their price target on CME Group from $246.00 to $252.00 and gave the stock an "underweight" rating in a research report on Thursday. UBS Group dropped their price target on CME Group from $305.00 to $285.00 and set a "neutral" rating on the stock in a research report on Monday, September 8th. Citigroup raised CME Group from a "neutral" rating to a "buy" rating and upped their price objective for the company from $275.00 to $300.00 in a research report on Thursday. Finally, Piper Sandler upped their price objective on CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a research report on Tuesday, July 15th. Five research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and three have assigned a Sell rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $268.14.

View Our Latest Research Report on CME

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.